Consistent with this observation, in breast cancer cell lines and mouse xenografts, Apigenin suppressed the nuclear factor erythroid 2-related factor 2 (Nrf2)-dependent antioxidant system through inhibition of PI3K/Akt axis [166]. This evidence concerns the gene AKT1 and breast cancer.